GlassScriptPhysician profile
Linda K Brown
NPI 1780678581
$1,505.40
in general payments reported to CMS, 2019-2025
23 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $181 · 2021: $201 · 2022: $229 · 2023: $300 · 2024: $251 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.40 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $206.94 | 2021-2025 | |
| Abbvie INC. | $189.85 | 2020-2023 | Lo Loestrin Fe |
| Pfizer INC. | $148.57 | 2021-2025 | |
| Organon LLC | $147.88 | 2022-2025 | Nexplanon, Nuvaring |
| Astellas Pharma US INC | $144.90 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $144.26 | 2020-2025 | Slynd |
| Hologic Sales and Service, LLC | $72.03 | 2019-2025 | Aptima, Thinprep 2000 Processor, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Agile Therapeutics, INC. | $58.88 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $54.81 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $41.03 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Lupin INC. | $35.35 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $33.62 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $33.33 | 2022-2023 | Vivjoa |
| Therapeuticsmd, INC. | $26.25 | 2020 | |
| Biogen, INC. | $24.80 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $23.10 | 2019 | |
| Evofem Biosciences, INC. | $20.54 | 2020 | |
| Mylan Pharmaceuticals INC. | $20.12 | 2019 | |
| Boston Scientific Corporation | $19.95 | 2023 | Wavewriter Alpha Prime 16 |
| Myovant Sciences INC. | $16.91 | 2022 | |
| Amag Pharmaceuticals, INC. | $16.11 | 2019 | |
| Sumitomo Pharma America, INC. | $14.98 | 2023 | Myfembree |
| Avion Pharmaceuticals | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.